$4.86 Billion is the total value of Granahan Investment Management's 186 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SSYS | New | STRATASYS LTD | $59,664 | – | 2,436,279 | +100.0% | 1.23% | – |
| New | LIFE TIME GROUP HOLDINGS INC | $59,273 | – | 3,444,123 | +100.0% | 1.22% | – | |
| New | FIRST WATCH RESTAURANT GROUP | $24,867 | – | 1,483,694 | +100.0% | 0.51% | – | |
| New | VITA COCO CO INC | $20,968 | – | 1,877,208 | +100.0% | 0.43% | – | |
| New | HAGERTY INC | $18,029 | – | 1,271,466 | +100.0% | 0.37% | – | |
| SRI | New | STONERIDGE INC | $10,370 | – | 525,311 | +100.0% | 0.21% | – |
| New | DEFINITIVE HEALTHCARE CORP | $8,155 | – | 298,385 | +100.0% | 0.17% | – | |
| HLIT | New | HARMONIC INC | $5,424 | – | 461,213 | +100.0% | 0.11% | – |
| New | ARTERIS INC | $4,782 | – | 226,531 | +100.0% | 0.10% | – | |
| AMN | New | AMN HEALTHCARE SVCS INC | $3,988 | – | 32,604 | +100.0% | 0.08% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $3,953 | – | 83,601 | +100.0% | 0.08% | – |
| PLRX | New | PLIANT THERAPEUTICS INC | $3,688 | – | 273,185 | +100.0% | 0.08% | – |
| New | PORTILLOS INC | $3,268 | – | 87,053 | +100.0% | 0.07% | – | |
| EVBG | New | EVERBRIDGE INC | $2,883 | – | 42,813 | +100.0% | 0.06% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $1,944 | – | 116,262 | +100.0% | 0.04% | – |
| New | XERIS BIOPHARMA HOLDINGS INC | $1,537 | – | 524,612 | +100.0% | 0.03% | – |
Other reporting managers
- Destra Capital Advisors LLC #1
Source
Signed by
- Susan Rawley — VP/Operations and Account Administration
- Granahan Investment Management holdings (13F-HR)
- Granahan Investment Management significant holdings (13D/G)
- Granahan Investment Management ownership history
- Granahan Investment Management portfolio value
- Granahan Investment Management filings
- Similar filers BETA
Compare quarterly holdings
Export Granahan Investment Management's holdings